Stay updated with breaking news from Liquidia Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On July 24, 2023, the United States Court of Appeals for the Federal Circuit issued a precedential opinion in United Therapeutics Corp. v. Liquidia Technologies, Inc. that affirmed the...
MORRISVILLE, N.C., Aug. 10, 2023 -- Liquidia Corporation today reported financial results for the second quarter ended June 30, 2023. The Company will host a webcast at 8:30 a.m. ET to discuss... -Today at 06:01 am- MarketScreener
No new clinical data is required to add PH-ILD indication as per FDA correspondenceRecertified that YUTREPIA does not infringe any valid patents listed in the Orange Book for TyvasoPreparing for...
United Therapeutics Corporation , a public benefit corporation, announced today that the United States Court of Appeals for the Federal Circuit affirmed the district court decision in the patent...
Infringement case now only focused on ‘793 patent, previously found to be invalid by PTAB in IPRFederal Circuit expected to hear appeal of PTAB decision in late 4th quarter 2023 to early 2024If PTAB...